Trazodone hydrochloride - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for trazodone hydrochloride and what is the scope of patent protection?

Trazodone hydrochloride is the generic ingredient in four branded drugs marketed by Angelini Pharma, Pragma, Accord Hlthcare, Alvogen, Am Therap, Apotex, Apotex Inc, Aurobindo Pharma, Fosun Pharma, Mylan, Mylan Pharms Inc, Oxford Pharms, Pliva, Quantum Pharmics, Rising, Sun Pharm Industries, Teva, Teva Pharms Usa, Torrent, Usl Pharma, Watson Labs, and Zydus Pharms, and is included in thirty-two NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Trazodone hydrochloride has seventy-eight patent family members in thirty countries.

There are thirteen drug master file entries for trazodone hydrochloride. Thirty-seven suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for trazodone hydrochloride

International Patents:	78
US Patents:	2
Tradenames:	4
Applicants:	22
NDAs:	32
Drug Master File Entries:	13
Finished Product Suppliers / Packagers:	37
Raw Ingredient (Bulk) Api Vendors:	134
Clinical Trials:	65
Patent Applications:	2,402
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for trazodone hydrochloride
What excipients (inactive ingredients) are in trazodone hydrochloride?	trazodone hydrochloride excipients list
DailyMed Link:	trazodone hydrochloride at DailyMed

Recent Clinical Trials for trazodone hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Alzheimer's Drug Discovery Foundation	Phase 3
Simon Ducharme, MD	Phase 3
University of New Mexico	Phase 4

See all trazodone hydrochloride clinical trials

Generic filers with tentative approvals for TRAZODONE HYDROCHLORIDE

Applicant	Application No.	Strength	Dosage Form
⤷ Sign Up	⤷ Sign Up	300MG	TABLET;ORAL
⤷ Sign Up	⤷ Sign Up	150MG	TABLET;ORAL
⤷ Sign Up	⤷ Sign Up	100MG	TABLET;ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for trazodone hydrochloride

Drug Class	Serotonin Reuptake Inhibitor

Medical Subject Heading (MeSH) Categories for trazodone hydrochloride

Anti-Anxiety Agents
Antidepressive Agents, Second-Generation
Serotonin Uptake Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for trazodone hydrochloride

N06AX	Other antidepressants
N06A	ANTIDEPRESSANTS
N06	PSYCHOANALEPTICS
N	Nervous system

Paragraph IV (Patent) Challenges for TRAZODONE HYDROCHLORIDE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
OLEPTRO	Extended-release Tablets	trazodone hydrochloride	150 mg and 300 mg	022411	1	2010-10-18

US Patents and Regulatory Information for trazodone hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Am Therap	TRAZODONE HYDROCHLORIDE	trazodone hydrochloride	TABLET;ORAL	071140-001	Oct 29, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sun Pharm Industries	TRAZODONE HYDROCHLORIDE	trazodone hydrochloride	TABLET;ORAL	073137-003	Dec 22, 1995	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	TRAZODONE HYDROCHLORIDE	trazodone hydrochloride	TABLET;ORAL	070857-001	Oct 10, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Torrent	TRAZODONE HYDROCHLORIDE	trazodone hydrochloride	TABLET;ORAL	202180-004	Nov 27, 2013	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Angelini Pharma	OLEPTRO	trazodone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	022411-002	Feb 2, 2010		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y	Y		⤷ Sign Up
Watson Labs	TRAZODONE HYDROCHLORIDE	trazodone hydrochloride	TABLET;ORAL	071113-001	Nov 17, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for trazodone hydrochloride

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Angelini Pharma	OLEPTRO	trazodone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	022411-001	Feb 2, 2010	⤷ Sign Up	⤷ Sign Up
Pragma	DESYREL	trazodone hydrochloride	TABLET;ORAL	018207-003	Mar 25, 1985	⤷ Sign Up	⤷ Sign Up
Angelini Pharma	OLEPTRO	trazodone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	022411-002	Feb 2, 2010	⤷ Sign Up	⤷ Sign Up
Pragma	DESYREL	trazodone hydrochloride	TABLET;ORAL	018207-003	Mar 25, 1985	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for trazodone hydrochloride

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Eurasian Patent Organization	017019	ТРАЗОДОН И ГИДРОХЛОРИД ТРАЗОДОНА В ОЧИЩЕННОЙ ФОРМЕ (TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM)	⤷ Sign Up
Portugal	2178850		⤷ Sign Up
Denmark	2178850		⤷ Sign Up
China	101242856	Sustained drug release compositions	⤷ Sign Up
South Korea	101655455		⤷ Sign Up
Canada	2693095	TRAZODONE ET CHLORHYDRATE DE TRAZODONE SOUS FORME PURIFIEE (TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.